Krystal Biotech
KRYS
#2225
Rank
โ‚น854.61 B
Marketcap
โ‚น28,990
Share price
1.08%
Change (1 day)
168.58%
Change (1 year)

Revenue for Krystal Biotech (KRYS)

Revenue in 2026 (TTM): โ‚น37.41 Billion

According to Krystal Biotech's latest financial reports the company's current revenue (TTM ) is โ‚น39.96 Billion. In 2025 the company made a revenue of โ‚น34.93 Billion an increase over the revenue in the year 2024 that were of โ‚น24.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Krystal Biotech from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น37.41 B7.1%
2025 โ‚น34.93 B40.16%
2024 โ‚น24.92 B490.49%
2023 โ‚น4.22 B
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA